Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, N.E., MS-F76, Atlanta, GA, 30341, USA.
Chronic Disease Prevention and Health Promotion, Alaska Division of Public Health, Department of Health and Social Services, Anchorage, AK, 99503, USA.
J Community Health. 2017 Oct;42(5):956-961. doi: 10.1007/s10900-017-0341-8.
Cancer survivors who continue to smoke have poorer response to treatment, higher risk for future cancers and lower survival rates than those who quit tobacco after diagnosis. Despite the increased risk for negative health outcomes, tobacco use among Alaskan cancer survivors is 19%, among the highest in the nation. To characterize and address tobacco cessation needs among cancer survivors who called a quit line for help in quitting tobacco, Alaska's Comprehensive Cancer Control program initiated a novel partnership with the state's Tobacco Quit Line. Alaska's Tobacco Quit Line, a state-funded resource that provides confidential coaching, support, and nicotine replacement therapies for Alaskan adults who wish to quit using tobacco, was used to collect demographic characteristics, health behaviors, cessation referral methods and other information on users. From September 2013- December 2014, the Alaska Quit Line included questions about previous cancer status and other chronic conditions to assess this information from cancer survivors who continue to use tobacco. Alaska's Tobacco Quit Line interviewed 3,141 smokers, 129 (4%) of whom were previously diagnosed with cancer. Most cancer survivors who called in to the quit line were female (72%), older than 50 years of age (65%), white (67%), and smoked cigarettes (95%). Cancer survivors reported a higher prevalence of asthma, COPD and heart disease than the non-cancer cohort. Approximately 34% of cancer survivors were referred to the quit line by a health care provider. This report illustrates the need for health care provider awareness of persistent tobacco use among cancer survivors in Alaska. It also provides a sound methodologic design for assessing ongoing tobacco cessation needs among cancer survivors who call a quit line. This survey methodology can be adapted by other public health programs to address needs and increase healthy behaviors among individuals with chronic disease.
癌症幸存者如果继续吸烟，他们对治疗的反应会更差，未来患癌症的风险更高，生存率也比诊断后戒烟的患者低。尽管有更高的负面健康结果风险，但阿拉斯加癌症幸存者的烟草使用率为 19%，是全美最高的。为了描述和解决那些拨打戒烟热线寻求帮助的癌症幸存者的戒烟需求，阿拉斯加综合癌症控制项目与该州的烟草戒烟热线建立了一种新的合作关系。阿拉斯加的烟草戒烟热线是一个由州政府资助的资源，为希望戒烟的阿拉斯加成年人提供保密指导、支持和尼古丁替代疗法。该热线收集用户的人口统计特征、健康行为、戒烟推荐方法和其他信息。从 2013 年 9 月至 2014 年 12 月，阿拉斯加戒烟热线询问了以前的癌症状况和其他慢性疾病的信息，以评估继续使用烟草的癌症幸存者的信息。阿拉斯加的烟草戒烟热线采访了 3141 名吸烟者，其中 129 人（4%）以前被诊断患有癌症。拨打戒烟热线的癌症幸存者中，大多数是女性（72%）、年龄超过 50 岁（65%）、白人（67%）、吸烟（95%）。癌症幸存者报告说，他们患哮喘、COPD 和心脏病的比例高于非癌症组。大约 34%的癌症幸存者是由医疗保健提供者推荐到戒烟热线的。本报告说明了阿拉斯加医疗保健提供者需要意识到癌症幸存者持续吸烟的问题。它还为评估拨打戒烟热线的癌症幸存者的持续戒烟需求提供了一个合理的方法设计。这种调查方法可以被其他公共卫生项目采用，以满足慢性病患者的需求，增加健康行为。
